 Krishna Mallela
Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dystrophin | 7 | 2024 | 32 | 3.490 |
Why?
| | Utrophin | 6 | 2017 | 7 | 2.830 |
Why?
| | Microfilament Proteins | 6 | 2017 | 125 | 2.660 |
Why?
| | Calcium-Binding Proteins | 6 | 2017 | 209 | 2.290 |
Why?
| | Protein Binding | 17 | 2024 | 2110 | 2.000 |
Why?
| | Protein Unfolding | 6 | 2018 | 31 | 1.910 |
Why?
| | Actins | 6 | 2017 | 403 | 1.800 |
Why?
| | Interferon-alpha | 4 | 2018 | 193 | 1.790 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 108 | 1.580 |
Why?
| | Protein Folding | 15 | 2010 | 266 | 1.450 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 264 | 1.450 |
Why?
| | Thermodynamics | 12 | 2024 | 407 | 1.430 |
Why?
| | Protein Aggregates | 5 | 2018 | 67 | 1.300 |
Why?
| | Preservatives, Pharmaceutical | 3 | 2014 | 26 | 1.190 |
Why?
| | Cytochromes c | 6 | 2011 | 60 | 1.190 |
Why?
| | Antibodies, Monoclonal | 3 | 2018 | 1357 | 1.090 |
Why?
| | Protein Stability | 8 | 2021 | 160 | 0.980 |
Why?
| | Dystrophin-Associated Proteins | 1 | 2024 | 6 | 0.940 |
Why?
| | Benzyl Alcohol | 3 | 2014 | 12 | 0.930 |
Why?
| | Protein Conformation | 8 | 2018 | 854 | 0.920 |
Why?
| | Models, Molecular | 15 | 2018 | 1484 | 0.910 |
Why?
| | Immunoglobulin G | 2 | 2018 | 844 | 0.880 |
Why?
| | Calorimetry | 1 | 2024 | 64 | 0.880 |
Why?
| | Surface Plasmon Resonance | 1 | 2024 | 88 | 0.860 |
Why?
| | Protein Structure, Secondary | 14 | 2019 | 340 | 0.860 |
Why?
| | Protein Isoforms | 1 | 2024 | 378 | 0.830 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2022 | 14 | 0.820 |
Why?
| | Protein Structure, Tertiary | 10 | 2021 | 837 | 0.810 |
Why?
| | Mutation, Missense | 3 | 2014 | 315 | 0.790 |
Why?
| | Methionine | 2 | 2019 | 157 | 0.760 |
Why?
| | Anti-Infective Agents | 2 | 2014 | 245 | 0.710 |
Why?
| | Amyloid beta-Peptides | 1 | 2022 | 212 | 0.680 |
Why?
| | Asparagine | 1 | 2019 | 29 | 0.650 |
Why?
| | Drug Compounding | 2 | 2023 | 96 | 0.630 |
Why?
| | Protein Subunits | 2 | 2012 | 230 | 0.600 |
Why?
| | Horses | 9 | 2012 | 106 | 0.600 |
Why?
| | Excipients | 1 | 2018 | 51 | 0.590 |
Why?
| | Oxidants | 1 | 2018 | 106 | 0.580 |
Why?
| | Protein Domains | 3 | 2024 | 252 | 0.570 |
Why?
| | Polysorbates | 1 | 2017 | 38 | 0.560 |
Why?
| | Lymphokines | 1 | 2017 | 115 | 0.560 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2017 | 59 | 0.560 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2017 | 40 | 0.550 |
Why?
| | Ketones | 1 | 2017 | 47 | 0.550 |
Why?
| | Aldehydes | 1 | 2017 | 138 | 0.530 |
Why?
| | Recombinant Proteins | 5 | 2021 | 1291 | 0.510 |
Why?
| | Molecular Chaperones | 1 | 2017 | 182 | 0.510 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1003 | 0.500 |
Why?
| | Protein Denaturation | 5 | 2011 | 75 | 0.500 |
Why?
| | Light | 1 | 2018 | 353 | 0.490 |
Why?
| | Cresols | 2 | 2014 | 4 | 0.480 |
Why?
| | Kinetics | 11 | 2024 | 1623 | 0.470 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2044 | 0.460 |
Why?
| | Binding Sites | 4 | 2023 | 1244 | 0.450 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 281 | 0.430 |
Why?
| | Antiviral Agents | 1 | 2018 | 711 | 0.400 |
Why?
| | Biophysical Phenomena | 4 | 2015 | 64 | 0.350 |
Why?
| | Cytochrome c Group | 5 | 2004 | 42 | 0.350 |
Why?
| | Muscular Dystrophies | 1 | 2010 | 34 | 0.340 |
Why?
| | Mutation | 5 | 2022 | 3696 | 0.330 |
Why?
| | Molecular Sequence Data | 5 | 2015 | 2822 | 0.320 |
Why?
| | Proteins | 5 | 2024 | 936 | 0.310 |
Why?
| | Surface-Active Agents | 2 | 2020 | 84 | 0.290 |
Why?
| | Drug Stability | 2 | 2018 | 149 | 0.290 |
Why?
| | Hydrogen | 6 | 2004 | 65 | 0.280 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 4 | 2018 | 251 | 0.280 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 3178 | 0.270 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2017 | 138 | 0.250 |
Why?
| | Humans | 17 | 2024 | 128495 | 0.250 |
Why?
| | Circular Dichroism | 3 | 2017 | 148 | 0.250 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2024 | 2064 | 0.240 |
Why?
| | beta-Arrestins | 1 | 2024 | 13 | 0.230 |
Why?
| | Receptors, Opioid, mu | 1 | 2024 | 56 | 0.220 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2015 | 369 | 0.220 |
Why?
| | Molecular Docking Simulation | 1 | 2024 | 109 | 0.220 |
Why?
| | Entropy | 1 | 2024 | 39 | 0.220 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2024 | 89 | 0.220 |
Why?
| | Amino Acids | 2 | 2019 | 477 | 0.210 |
Why?
| | Morphine | 1 | 2024 | 127 | 0.210 |
Why?
| | Protein Interaction Mapping | 1 | 2024 | 108 | 0.210 |
Why?
| | Receptors, Virus | 1 | 2023 | 83 | 0.210 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2023 | 104 | 0.210 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2022 | 31 | 0.200 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2022 | 17 | 0.200 |
Why?
| | HEK293 Cells | 2 | 2024 | 683 | 0.200 |
Why?
| | Mutant Proteins | 2 | 2014 | 99 | 0.200 |
Why?
| | Benzoquinones | 1 | 2022 | 47 | 0.200 |
Why?
| | Fluorescent Dyes | 4 | 2012 | 313 | 0.200 |
Why?
| | NAD | 1 | 2022 | 72 | 0.200 |
Why?
| | Deuterium Exchange Measurement | 3 | 2007 | 29 | 0.190 |
Why?
| | Immune Evasion | 1 | 2022 | 55 | 0.190 |
Why?
| | Antigen-Antibody Reactions | 1 | 2021 | 51 | 0.190 |
Why?
| | Transition Temperature | 1 | 2021 | 27 | 0.190 |
Why?
| | Cell Proliferation | 2 | 2018 | 2345 | 0.180 |
Why?
| | Dependovirus | 1 | 2021 | 62 | 0.170 |
Why?
| | Protein Multimerization | 2 | 2012 | 178 | 0.170 |
Why?
| | Animals | 12 | 2022 | 34647 | 0.170 |
Why?
| | Genetic Vectors | 1 | 2021 | 311 | 0.160 |
Why?
| | Escherichia coli | 2 | 2014 | 771 | 0.160 |
Why?
| | tert-Butylhydroperoxide | 1 | 2018 | 9 | 0.150 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2017 | 510 | 0.150 |
Why?
| | Amidines | 1 | 2018 | 16 | 0.150 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2019 | 359 | 0.150 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2018 | 41 | 0.150 |
Why?
| | Protein Aggregation, Pathological | 1 | 2018 | 16 | 0.150 |
Why?
| | Temperature | 2 | 2012 | 632 | 0.150 |
Why?
| | Models, Biological | 4 | 2008 | 1698 | 0.150 |
Why?
| | Proteolysis | 1 | 2018 | 162 | 0.150 |
Why?
| | Receptors, Fc | 1 | 2018 | 52 | 0.140 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 53 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 7 | 2007 | 541 | 0.140 |
Why?
| | Hydrolysis | 1 | 2017 | 184 | 0.140 |
Why?
| | Molecular Weight | 1 | 2017 | 331 | 0.140 |
Why?
| | Solubility | 1 | 2017 | 234 | 0.140 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 758 | 0.130 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 186 | 0.130 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 310 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2018 | 196 | 0.130 |
Why?
| | Adenosine Triphosphatases | 1 | 2017 | 161 | 0.130 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 25 | 0.130 |
Why?
| | Carbocyanines | 3 | 2001 | 33 | 0.120 |
Why?
| | Nanoparticles | 1 | 2020 | 369 | 0.120 |
Why?
| | Mass Spectrometry | 1 | 2018 | 663 | 0.120 |
Why?
| | Ethylene Glycols | 1 | 2014 | 15 | 0.110 |
Why?
| | Phenol | 1 | 2014 | 19 | 0.110 |
Why?
| | SUMO-1 Protein | 1 | 2014 | 20 | 0.110 |
Why?
| | Bacterial Load | 1 | 2014 | 66 | 0.110 |
Why?
| | Cysteine Endopeptidases | 1 | 2014 | 68 | 0.110 |
Why?
| | Chromatography, Gel | 1 | 2014 | 127 | 0.110 |
Why?
| | Biochemistry | 2 | 2008 | 38 | 0.110 |
Why?
| | Area Under Curve | 1 | 2014 | 293 | 0.110 |
Why?
| | Cloning, Molecular | 1 | 2014 | 522 | 0.100 |
Why?
| | Pyrenes | 1 | 2012 | 6 | 0.100 |
Why?
| | Crystallography, X-Ray | 1 | 2014 | 434 | 0.100 |
Why?
| | Solutions | 1 | 2012 | 148 | 0.100 |
Why?
| | In Vitro Techniques | 2 | 2010 | 1047 | 0.100 |
Why?
| | Cysteine | 1 | 2012 | 183 | 0.090 |
Why?
| | Caveolae | 1 | 2001 | 16 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 636 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2012 | 330 | 0.090 |
Why?
| | Cattle | 1 | 2014 | 965 | 0.090 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2014 | 378 | 0.090 |
Why?
| | Membrane Lipids | 1 | 2001 | 90 | 0.090 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 143 | 0.080 |
Why?
| | Solvents | 1 | 2010 | 108 | 0.080 |
Why?
| | Anesthetics, Local | 1 | 2010 | 74 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 2 | 2005 | 171 | 0.080 |
Why?
| | Multiprotein Complexes | 1 | 2010 | 148 | 0.080 |
Why?
| | Lipid Bilayers | 1 | 1999 | 98 | 0.080 |
Why?
| | Cell Line | 1 | 2014 | 2741 | 0.080 |
Why?
| | Micrococcal Nuclease | 1 | 2008 | 22 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3387 | 0.070 |
Why?
| | Phosphatidylcholines | 1 | 1997 | 146 | 0.070 |
Why?
| | Liposomes | 1 | 1997 | 168 | 0.060 |
Why?
| | Methyl Ethers | 1 | 2005 | 8 | 0.060 |
Why?
| | Receptors, GABA | 1 | 2005 | 9 | 0.060 |
Why?
| | Models, Chemical | 4 | 2008 | 263 | 0.060 |
Why?
| | Halothane | 1 | 2005 | 6 | 0.060 |
Why?
| | Anesthetics, Inhalation | 1 | 2005 | 16 | 0.060 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 202 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2021 | 162 | 0.040 |
Why?
| | Fluorescence Polarization | 2 | 2001 | 38 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2021 | 292 | 0.040 |
Why?
| | Particle Size | 1 | 2020 | 352 | 0.040 |
Why?
| | Egg Proteins | 1 | 2007 | 17 | 0.030 |
Why?
| | Muramidase | 1 | 2007 | 77 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 889 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2005 | 211 | 0.030 |
Why?
| | Probability | 1 | 2005 | 306 | 0.030 |
Why?
| | Time Factors | 2 | 2004 | 6505 | 0.030 |
Why?
| | Biophysics | 1 | 2002 | 69 | 0.020 |
Why?
| | Tritium | 1 | 2001 | 75 | 0.020 |
Why?
| | Hydrogen Bonding | 1 | 2001 | 149 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2001 | 140 | 0.020 |
Why?
| | Rotation | 1 | 2001 | 111 | 0.020 |
Why?
| | History, 20th Century | 1 | 2001 | 288 | 0.020 |
Why?
| | Surface Properties | 1 | 2001 | 394 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2001 | 488 | 0.020 |
Why?
| | Sucrose | 1 | 1999 | 99 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1999 | 95 | 0.020 |
Why?
| | Guanidine | 1 | 2008 | 22 | 0.020 |
Why?
| | Molecular Structure | 1 | 1999 | 466 | 0.020 |
Why?
| | Enzyme Stability | 1 | 2007 | 67 | 0.020 |
Why?
| | Amides | 1 | 2007 | 90 | 0.020 |
Why?
| | Protons | 1 | 2006 | 80 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2008 | 542 | 0.010 |
Why?
| | Titrimetry | 1 | 2003 | 10 | 0.010 |
Why?
| | Spectrum Analysis | 1 | 2003 | 88 | 0.010 |
Why?
| | Proteomics | 1 | 2008 | 1018 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3021 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2005 | 2516 | 0.010 |
Why?
|
|
Mallela's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|